Related Experiment Video
Updated: May 14, 2026
06:58
Frailty Assessment in an Aging Mouse Model
Published on: September 23, 2025
Frailty and incident dementia
Shelly L Gray1, Melissa L Anderson, Rebecca A Hubbard
1PharmD, MS, School of Pharmacy, University of Washington, Box 357630, Seattle, WA 98195-7630, USA. slgray@u.washington.edu
Summary
Frailty is linked to a higher risk of non-Alzheimer's disease dementia. While not associated with all dementia in fully adjusted models, frailty showed a link in individuals with higher cognitive function.
Area of Science:
- Gerontology
- Neurology
- Public Health
Background:
- Investigating the relationship between physical frailty and cognitive decline.
- Examining frailty as a potential risk factor for dementia, Alzheimer's disease (AD), and non-AD dementia.
Purpose of the Study:
- To determine if frailty is associated with the risk of developing dementia, AD, and non-AD dementia in older adults.
- To explore potential interactions between frailty and cognitive status in dementia risk.
Main Methods:
- Prospective population-based cohort study of 2,619 participants aged 65+ without dementia at baseline.
- Frailty defined by at least 3 criteria: weakness, slowness, weight loss, low physical activity, exhaustion.
- Adjusted Cox proportional hazards models used to analyze associations over a mean 6.5-year follow-up.
Main Results:
- Frailty was associated with dementia risk when only adjusting for demographics (HR 1.78).
- In fully adjusted models, frailty showed no significant association with all-cause dementia (HR 1.20) or AD (HR 1.08).
- Frailty was significantly associated with increased risk of non-AD dementia (HR 2.57) and with all-cause dementia in those with higher baseline cognition.
Conclusions:
- Frailty is linked to non-AD dementia but not AD dementia in fully adjusted models.
- The association between frailty and all-cause dementia is dependent on baseline cognitive function.
- Further research is needed to understand the mechanisms linking frailty and dementia subtypes.
More Related Videos
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...